OTC drugs

Having come from the pharmaceutical world, I tend to be on the supportive side of the industry because I spent more than 20 years finding out how insanely difficult it is to get a drug from the earliest stages (drug discovery) 

Back in 2019, I wrote about some of the tricks that drug companies use to hang onto brand name sales even though the drug's generic equivalent may have been around for years, if not decades (See 

In a just published perspective piece in The New England Journal of Medicine, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D.